InterMune initiated by Thomas Weisel at peer perform

InterMune Inc. coverage was initiated by Thomas Weisel Partners analyst Joe Slavinsky at a peer perform rating. Thomas Weisel believes InterMune's pipeline represents significant value and that the long-term prospects for the company are compelling. Over the next six to 12 months, however, the firm expects the lack of significant catalysts, coupled with unpredictable sales from Actimmune, to lead to performance in line with its peer group. InterMune shares Wednesday were up $0.03, or 0.19%, at $16.03 on volume of 311,100 shares versus the three-month running average of 343,098 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.